Wednesday, 7 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange

Aarti Pharmalabs Ltd

NSE: AARTIPHARM · BSE: 543748 · Pharmaceuticals & Biotechnology · 34 announcements

Share price
₹954.00
Market cap
₹8,651 Cr
Revenue (annual)
₹1,819 Cr
Net profit (annual)
₹174.7 Cr
P/E (TTM)
40.6×Sector 47.4×
Promoter holding
42.86%-0.22% QoQ
FII holding
8.17%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

18:50 IST BSE
Management Change

Aarti Pharmalabs Management Change

Aarti Pharmalabs reported directorate changes, including Shri Rashesh Gogri's appointment as Managing Director, Smt. Hetal Gogri Gala's re-designation, and the cessation of Shri Rajendra Gogri.

19:44 IST BSE
Management Change

Aarti Pharmalabs Management Change

Shri G.M. Naidu, Manufacturing/Sr. General Manager, has resigned from Aarti Pharmalabs Limited. He will be relieved from his duties effective August 31, 2026.

20:08 IST NSE
Management Change

Aarti Pharmalabs Management Change

Aarti Pharmalabs Ltd reported changes in designation for directors Mr. Rashesh C. Gogri and Ms. Hetal Gogri Gala, effective October 1, 2026.

22:27 IST NSE
Management Change

Aarti Pharmalabs Management Change

Aarti Pharmalabs re-appointed its cost and internal auditors for 12 months. Additionally, Rajendra Pagare and Sachin Patil were designated as Senior Management Personnel.

Execution
12 months for auditors